应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02487 科笛-B
交易中 10-06 10:14:04
0.945
-0.085
-8.25%
最高
0.965
最低
0.900
成交量
22.58万
今开
0.965
昨收
1.030
日振幅
6.31%
总市值
3.52亿
流通市值
3.52亿
总股本
3.73亿
成交额
20.99万
换手率
0.06%
流通股本
3.73亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
科笛-B回购4.08万股,耗资约3.97万港元
公告速递 · 06:11
科笛-B回购4.08万股,耗资约3.97万港元
科笛-B回购42,000股股份,总额约4.15万港元
公告速递 · 10-05 08:05
科笛-B回购42,000股股份,总额约4.15万港元
科笛-B(02487.HK)10月2日斥资4.15万港元回购4.2万股
智通财经 · 10-05 08:05
科笛-B(02487.HK)10月2日斥资4.15万港元回购4.2万股
科笛-B9月股份变动月报:股本维持稳定
公告速递 · 10-02
科笛-B9月股份变动月报:股本维持稳定
科笛-B:张乐乐减持,好仓比例降至7.09%
港股披露 · 10-02
科笛-B:张乐乐减持,好仓比例降至7.09%
科笛-B:张乐乐减持,好仓比例降至6.74%
港股披露 · 10-02
科笛-B:张乐乐减持,好仓比例降至6.74%
科笛-B(02487)公布董事会及三大专门委员会最新组成
公告速递 · 09-30
科笛-B(02487)公布董事会及三大专门委员会最新组成
科笛-B(02487)启动股份回购计划 2026年内最高回购3,633.68万股、耗资上限30.0百万元人民币
公告速递 · 09-30
科笛-B(02487)启动股份回购计划 2026年内最高回购3,633.68万股、耗资上限30.0百万元人民币
科笛-B(02487)拟实施股份购回计划
智通财经 · 09-30
科笛-B(02487)拟实施股份购回计划
科笛-B(02487)高层调整:黄雨青辞任执行董事兼CFO,雷磊博士接任执行董事
公告速递 · 09-30
科笛-B(02487)高层调整:黄雨青辞任执行董事兼CFO,雷磊博士接任执行董事
科笛-B(02487):雷磊获委任为执行董事
智通财经 · 09-30
科笛-B(02487):雷磊获委任为执行董事
科笛-B:张乐乐减持,好仓比例降至7.12%
港股披露 · 09-25
科笛-B:张乐乐减持,好仓比例降至7.12%
科笛-B:张乐乐减持,好仓比例降至7.29%
港股披露 · 09-25
科笛-B:张乐乐减持,好仓比例降至7.29%
科笛-B:张乐乐减持,好仓比例降至7.32%
港股披露 · 09-25
科笛-B:张乐乐减持,好仓比例降至7.32%
科笛-B 2026年中期财报:营收62.7百万元,经调整净亏损1.74亿元
公告速递 · 09-24
科笛-B 2026年中期财报:营收62.7百万元,经调整净亏损1.74亿元
港股异动 | 科笛-B(02487.HK)涨超3% 近日CU-40102获澳门药物监督管理局上市批准
智通财经 · 09-24
港股异动 | 科笛-B(02487.HK)涨超3% 近日CU-40102获澳门药物监督管理局上市批准
科笛-B旗下产品Cu-40102获批上市,澳门药监局放行
美股速递 · 09-21
科笛-B旗下产品Cu-40102获批上市,澳门药监局放行
科笛-B创历史新低
格隆汇 · 09-15
科笛-B创历史新低
科笛-B8月股份变动月报:股本维持稳定
公告速递 · 09-04
科笛-B8月股份变动月报:股本维持稳定
科笛-B(02487):CU-20101(注射用A型肉毒毒素)生物制品上市许可申请获得国家药监局受理
智通财经 · 09-03
科笛-B(02487):CU-20101(注射用A型肉毒毒素)生物制品上市许可申请获得国家药监局受理
加载更多
公司概况
公司名称:
科笛-B
所属市场:
SEHK
上市日期:
--
主营业务:
科笛集团是一家主要从事皮肤学生物制药业务的投资控股公司。该公司致力于皮肤病治疗及护理市场中开发解决方案,涵盖毛发疾病及护理、皮肤疾病及护理、表皮麻醉以及局部脂肪堆积管理。该公司主要从事毛发疾病及护理产品以及若干护肤产品的分销。该公司的主要管线产品包括外用非那雄胺喷雾剂CU-40102、外用4%米诺环素泡沫剂CU-10201、外用新型小分子药剂CU-10101、局部外用利多卡因丁卡因乳膏剂CU-30101和重组突变胶原酶CU-20401。
发行价格:
--
{"stockData":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"科笛-B","latestPrice":0.945,"timestamp":1791252720728,"preClose":1.03,"halted":0,"volume":225800,"delay":0,"changeRate":-0.08252427184466027,"floatShares":373000000,"shares":373000000,"eps":-1.03,"marketStatus":"交易中","change":-0.085,"latestTime":"10-06 10:14:04","open":0.965,"high":0.965,"low":0.9,"amount":209870,"amplitude":0.063107,"askPrice":0.945,"askSize":2200,"bidPrice":0.93,"bidSize":5000,"shortable":0,"etf":0,"ttmEps":-0.868,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1791259200000},"marketStatusCode":2,"adr":0,"listingDate":1686499200000,"exchange":"SEHK","adjPreClose":1.03,"openAndCloseTimeList":[[1791250200000,1791259200000],[1791262800000,1791273600000]],"volumeRatio":1.01076,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02487","defaultTab":"news","newsList":[{"id":"1125492982","title":"科笛-B回购4.08万股,耗资约3.97万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125492982","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125492982?lang=zh_cn&edition=full","pubTime":"2026-10-06 06:11","pubTimestamp":1791238282,"startTime":"0","endTime":"0","summary":"科笛-B于2026年10月6日发布公告,披露公司于2026年10月5日在香港联交所场内回购4.08万股普通股,占当日回购前已发行股份约0.01093%。此次回购价格区间介乎每股港币0.955至1.03港元,合计涉资约3.97万港元。回购完成后,公司已发行股份总数仍为374,533,891股,其中373,088,491股为已发行股份,库存股份增至1,445,400股。截至本次回购后,公司已根据授权累计回购82,800股,占决议获通过当日已发行股份数目的约0.02279%,剩余可回购股数约为36,254,027股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"科笛-B回购4.08万股,耗资约3.97万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157348838","title":"科笛-B回购42,000股股份,总额约4.15万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157348838","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157348838?lang=zh_cn&edition=full","pubTime":"2026-10-05 08:05","pubTimestamp":1791158754,"startTime":"0","endTime":"0","summary":"科笛-B于2026年10月5日发布公告,披露最新股份回购及已发行股本变化情况。本次回购每股价格介乎每股0.94港元至1.015港元,总耗资约4.15万港元。回购完成后,公司已发行股本为373,129,291股,库藏股为1,404,600股,总股本仍为374,533,891股。公司回购授权相关决议通过日期为2026年6月26日,可回购股份总数为36,336,827股。截至本次回购完成后,科笛-B合计回购42,000股,占授权通过当日已发行股本的约0.01156%。据悉,公告由执行董事张乐乐签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科笛-B回购42,000股股份,总额约4.15万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673779566","title":"科笛-B(02487.HK)10月2日斥资4.15万港元回购4.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673779566","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673779566?lang=zh_cn&edition=full","pubTime":"2026-10-05 08:05","pubTimestamp":1791158720,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167420540","title":"科笛-B9月股份变动月报:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1167420540","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167420540?lang=zh_cn&edition=full","pubTime":"2026-10-02 21:01","pubTimestamp":1790946114,"startTime":"0","endTime":"0","summary":"科笛集团于2026年10月2日发布截至2026年9月30日的股份变动月报表。报告显示,公司法定/注册股本为2,500,000,000股普通股,每股面值0.00002美元,合计50,000美元,与上月底持平。期末已发行股份为373,171,291股,库存股份1,362,600股,合计374,533,891股,亦无变动。公司同时确认其公众持股量符合香港联交所相关要求。同一计划下的股份奖励则由6,297,640股降至6,062,544股,当月共有235,096股被没收。公司表示,将继续遵守香港联交所《上市规则》及相关法律规定。本次公告由执行董事张乐乐签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133648828","title":"科笛-B:张乐乐减持,好仓比例降至7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133648828","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133648828?lang=zh_cn&edition=full","pubTime":"2026-10-02 18:00","pubTimestamp":1790935248,"startTime":"0","endTime":"0","summary":"张乐乐于2026年9月25日在联交所场内因证券公司通过保证金证券账户强制卖出(forced sale)其持有的科笛-B股份,涉及9.10万股,每股均价0.9597港元,涉资约8.73万港元。该笔为场内主动交易,属二级市场直接买卖。张乐乐此次减持前持有科笛-B好仓2665.31万股,占比7.12%;减持后持股量为2656.21万股,好仓比例降至7.09%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163712919","title":"科笛-B:张乐乐减持,好仓比例降至6.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1163712919","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163712919?lang=zh_cn&edition=full","pubTime":"2026-10-02 17:34","pubTimestamp":1790933671,"startTime":"0","endTime":"0","summary":"张乐乐于2026年9月28日在联交所场内以每股均价0.7784港元卖出科笛-B股份130.28万股,涉资约101.41万港元,属场内主动交易,即在二级市场直接买卖股份。张乐乐此次减持前持有科笛-B好仓2656.21万股,占比7.09%;减持后持股量为2525.93万股,好仓比例降至6.74%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134201704","title":"科笛-B(02487)公布董事会及三大专门委员会最新组成","url":"https://stock-news.laohu8.com/highlight/detail?id=1134201704","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134201704?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:50","pubTimestamp":1790758225,"startTime":"0","endTime":"0","summary":"2026年9月30日,科笛集团有限公司公告披露,公司董事会及下设专门委员会成员组成如下:。截至公告日,董事会共计9名成员,其中执行董事2名、非执行董事4名、独立非执行董事3名。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140889844","title":"科笛-B(02487)启动股份回购计划 2026年内最高回购3,633.68万股、耗资上限30.0百万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1140889844","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140889844?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:48","pubTimestamp":1790758086,"startTime":"0","endTime":"0","summary":"科笛-B(02487)9月30日自愿公告称,公司董事会已批准自2026年10月02日至2026年12月31日(含首尾两日)实施股份回购计划。该计划将依据公司于2026年06月26日股东周年大会获授的一般性股份购回授权执行。公司最多可于公开市场回购36,336,827股股份,资金上限为人民币30.0百万元(约合34.9百万元港元)。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671740562","title":"科笛-B(02487)拟实施股份购回计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2671740562","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671740562?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:40","pubTimestamp":1790757658,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科笛-B 发布公告,本公司拟实施由2026年10月2日至2026年12月31日的股份购回计划。于本公告日期,董事会不拟悉数实施股份购回计划项下的股份购回。董事会相信,股份购回计划可展示本公司对其业务的长远前景充满信心,且最终会为本公司带来裨益,同时为股东创造价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146006122","title":"科笛-B(02487)高层调整:黄雨青辞任执行董事兼CFO,雷磊博士接任执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1146006122","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146006122?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:39","pubTimestamp":1790757590,"startTime":"0","endTime":"0","summary":"2026年9月30日,科笛-B公告称,自即日起,公司执行董事兼首席财务官黄雨青先生因专注其他个人事务,已辞去以上职务。黄雨青确认与董事会无意见分歧,亦无其他事项需提请股东或香港联合交易所有限公司关注。同日,公司董事会委任雷磊博士为执行董事,任期三年,自2026年9月30日起生效,并将在下一届股东周年大会上轮值退任及获选连任。公司董事会对黄雨青先生在任期间的贡献表示感谢,并欢迎雷磊博士加入董事会。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671274916","title":"科笛-B(02487):雷磊获委任为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2671274916","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671274916?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:32","pubTimestamp":1790757128,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科笛-B(02487)发布公告,黄雨青因希望更专注于其他个人事务,已辞任公司执行董事及首席财务官,自2026年9月30日起生效。雷磊获委任为执行董事,自2026年9月30日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144014411","title":"科笛-B:张乐乐减持,好仓比例降至7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144014411","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144014411?lang=zh_cn&edition=full","pubTime":"2026-09-25 17:42","pubTimestamp":1790329368,"startTime":"0","endTime":"0","summary":"张乐乐于2026年9月24日在联交所场内以每股均价1.007港元卖出科笛-B股份65.38万股,涉资约65.84万港元。该笔为因保证金追缴导致的强制卖出,属场内主动交易,即在二级市场直接买卖股份。张乐乐此次减持前持有科笛-B好仓2730.69万股,占比7.29%;减持后持股量为2665.31万股,好仓比例降至7.12%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156172536","title":"科笛-B:张乐乐减持,好仓比例降至7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156172536","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156172536?lang=zh_cn&edition=full","pubTime":"2026-09-25 17:33","pubTimestamp":1790328815,"startTime":"0","endTime":"0","summary":"张乐乐于2026年9月23日在联交所场内以每股均价1.064港元卖出科笛-B股份11.34万股,涉资约12.07万港元,属场内主动交易,即在二级市场直接买卖股份。张乐乐此次减持前持有科笛-B好仓2742.03万股,占比7.32%;减持后持股量为2730.69万股,好仓比例降至7.29%。Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118653775","title":"科笛-B:张乐乐减持,好仓比例降至7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118653775","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118653775?lang=zh_cn&edition=full","pubTime":"2026-09-25 17:12","pubTimestamp":1790327558,"startTime":"0","endTime":"0","summary":"张乐乐于2026年9月22日因证券公司强制平仓,在联交所场内以每股均价1.0842港元卖出科笛-B股份13.68万股,涉资约14.83万港元,属场内主动交易,即在二级市场直接买卖股份。张乐乐此次减持前持有科笛-B好仓2755.71万股,占比7.36%;减持后持股量为2742.03万股,好仓比例降至7.32%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113173235","title":"科笛-B 2026年中期财报:营收62.7百万元,经调整净亏损1.74亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113173235","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113173235?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:36","pubTimestamp":1790238991,"startTime":"0","endTime":"0","summary":"科笛-B公布的2026年中期财报显示,报告期内营收为62.7百万元,同比减少5.4%。本期经调整净亏损为1.74亿元,相比上年同期的2.18亿元,减亏幅度约20%。从成本结构来看,销售及分销开支约为57.4百万元,同比下降37.4%,研发成本53.2百万元,同比下降32.6%,管理费用47.6百万元,同比下降25.9%。毛利率也由上年同期的54.7%下降至48%。经营活动所用现金流量净额从1.72亿元收窄至1.06亿元,降幅约38.5%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"科笛-B 2026年中期财报:营收62.7百万元,经调整净亏损1.74亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669045361","title":"港股异动 | 科笛-B(02487.HK)涨超3% 近日CU-40102获澳门药物监督管理局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2669045361","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669045361?lang=zh_cn&edition=full","pubTime":"2026-09-24 10:16","pubTimestamp":1790216218,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02487","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156384796","title":"科笛-B旗下产品Cu-40102获批上市,澳门药监局放行","url":"https://stock-news.laohu8.com/highlight/detail?id=1156384796","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156384796?lang=zh_cn&edition=full","pubTime":"2026-09-21 06:34","pubTimestamp":1789943658,"startTime":"0","endTime":"0","summary":"科笛-B(CUTIA-B)宣布,其核心产品Cu-40102已成功获得澳门药物监督管理局的上市许可。这一里程碑式的进展,标志着该产品在澳门市场的商业化进程正式拉开帷幕。此次获批,不仅为科笛-B的业务版图添上了浓墨重彩的一笔,也预示着公司在区域医疗健康领域的影响力有望进一步扩大。从监管审批到市场准入,Cu-40102迈出的每一步都备受瞩目,而如今,它终于迎来了关键的转折点。值得注意的是,澳门药监局的这一决定,是基于对该产品安全性、有效性及质量的严格审查。对于科笛-B而言,这无疑是一个积极的信号,为其后续在更广泛市场的拓展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667861256","title":"科笛-B创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2667861256","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667861256?lang=zh_cn&edition=full","pubTime":"2026-09-15 15:21","pubTimestamp":1789456886,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143769268","title":"科笛-B8月股份变动月报:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1143769268","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143769268?lang=zh_cn&edition=full","pubTime":"2026-09-04 21:05","pubTimestamp":1788527144,"startTime":"0","endTime":"0","summary":"科笛-B于2026年9月4日发布截至2026年8月31日的证券变动月报表。公告显示,公司注册股本保持在2,500,000,000股普通股,面值为每股0.00002美元,总注册股本50,000美元,较上月无变化。首次公开发售后股权激励计划未见新增或变动。公告显示,科笛-B确认在报告期内遵守香港联交所上市规则及其他相关法律法规。上述月报由公司执行董事张乐乐签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664441668","title":"科笛-B(02487):CU-20101(注射用A型肉毒毒素)生物制品上市许可申请获得国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664441668","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664441668?lang=zh_cn&edition=full","pubTime":"2026-09-03 06:23","pubTimestamp":1788387807,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科笛-B(02487)发布公告,集团CU-20101(注射用A型肉毒毒素)的生物制品上市许可申请(BLA)已获得中国家药品监督管理局受理,适应症为用于改善中度至重度眉间纹。CU-20101在生产工艺过程中将不使用动物源性材料和人血白蛋白,从而消除传染性海绵状脑病(TSE)感染和相关过敏反应风险,预计将具有良好的安全性优势。 CU-20101将进一步丰富集团的皮肤产品矩阵,并有利于与集团现有产品形成协同效应。面向皮肤治疗市场广泛的需求,多元化产品的布局将有望为集团取得更大的市场份额。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02487","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cutiatx.com","stockEarnings":[{"period":"1week","weight":0.1444},{"period":"1month","weight":-0.4097},{"period":"3month","weight":-0.6113},{"period":"6month","weight":-0.7741},{"period":"1year","weight":-0.8844},{"period":"ytd","weight":-0.7731}],"compareEarnings":[{"period":"1week","weight":-0.0244},{"period":"1month","weight":-0.0628},{"period":"3month","weight":0.0231},{"period":"6month","weight":-0.0716},{"period":"1year","weight":-0.1142},{"period":"ytd","weight":-0.062}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科笛集团是一家主要从事皮肤学生物制药业务的投资控股公司。该公司致力于皮肤病治疗及护理市场中开发解决方案,涵盖毛发疾病及护理、皮肤疾病及护理、表皮麻醉以及局部脂肪堆积管理。该公司主要从事毛发疾病及护理产品以及若干护肤产品的分销。该公司的主要管线产品包括外用非那雄胺喷雾剂CU-40102、外用4%米诺环素泡沫剂CU-10201、外用新型小分子药剂CU-10101、局部外用利多卡因丁卡因乳膏剂CU-30101和重组突变胶原酶CU-20401。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.167612},{"month":2,"riseRate":0.666667,"avgChangeRate":0.117769},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.042532},{"month":4,"riseRate":0,"avgChangeRate":-0.028062},{"month":5,"riseRate":0.333333,"avgChangeRate":0.125792},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.095432},{"month":7,"riseRate":0.25,"avgChangeRate":0.041528},{"month":8,"riseRate":0.75,"avgChangeRate":0.153996},{"month":9,"riseRate":0.25,"avgChangeRate":-0.158782},{"month":10,"riseRate":0.5,"avgChangeRate":-0.088453},{"month":11,"riseRate":0,"avgChangeRate":-0.186326},{"month":12,"riseRate":0,"avgChangeRate":-0.277493}],"exchange":"SEHK","name":"科笛-B","nameEN":"CUTIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科笛-B,02487,科笛-B股票,科笛-B股票老虎,科笛-B股票老虎国际,科笛-B行情,科笛-B股票行情,科笛-B股价,科笛-B股市,科笛-B股票价格,科笛-B股票交易,科笛-B股票购买,科笛-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}